37 results on '"Hansen, Torben F."'
Search Results
2. 2220: Robust optimization of the GTV is able to reduce normal tissue irradiation in lung SBRT
3. The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study
4. Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma
5. Programmed Death Ligand-1 expression in stage II colon cancer - experiences from a nationwide populationbased cohort
6. Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?
7. The Soluble Urokinase-Type Plasminogen Activator Receptor as a Biomarker for Survival and Early Treatment Effect in Metastatic Colorectal Cancer
8. Early ctDNA response to chemotherapy. A potential surrogate marker for overall survival
9. The importance of −460 C/T and +405 G/C single nucleotide polymorphisms to the function of vascular endothelial growth factor A in colorectal cancer
10. Supplementary_material_3 – Supplemental material for Early identification of treatment benefit by methylated circulating tumor DNA in metastatic colorectal cancer
11. The Prognostic Value of Tumor-Infiltrating lymphocytes in Stage II Colon Cancer. A Nationwide Population-Based Study1
12. Comparison of Mutated KRAS and Methylated HOXA9 Tumor-Specific DNA in Advanced Lung Adenocarcinoma
13. High expression of microRNA-625–3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer
14. Non-CpG island promoter hypomethylation and miR-149 regulate the expression of SRPX2 in colorectal cancer
15. Early identification of treatment benefit by methylated circulating tumor DNA in metastatic colorectal cancer
16. Phase II study of gemcitabine, oxaliplatin and capecitabine in patients with KRAS exon 2 mutated biliary tract cancers
17. Correlation Between Tumor-Specific Mutated and Methylated DNA in Colorectal Cancer
18. The prognostic value of tumour stroma ratio in stage II colon cancer
19. Circulating miRNAs in localized/locally advanced prostate cancer patients after radical prostatectomy and radiotherapy
20. Phase II study of gemcitabine, oxaliplatin and capecitabine in patients with KRAS exon 2 mutated biliary tract cancers.
21. Computer-assisted stereology and automated image analysis for quantification of tumor infiltrating lymphocytes in colon cancer
22. Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
23. Circulating miRNAs in localized/locally advanced prostate cancer patients after radical prostatectomy and radiotherapy.
24. Stroma-High Lymph Node Involvement Predicts Poor Survival More Accurately for Patients with Stage III Colon Cancer
25. Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature
26. Tissue MicroRNAs as Predictors of Outcome in Patients with Metastatic Colorectal Cancer Treated with First Line Capecitabine and Oxaliplatin with or without Bevacizumab
27. Abstract LB-174: MicroRNA-126 (miR-126) and epidermal growth factor-like domain 7 (EGFL7) in Bevacizumab-treated patients with metastatic colorectal cancer
28. Functional Screening Identifies miRNAs Influencing Apoptosis and Proliferation in Colorectal Cancer
29. Abstract 1157: MicroRNA-625-3p is associated with response to first-line oxaliplatin-based treatment of metastatic colorectal cancer.
30. The Prognostic Value of Haplotypes in the Vascular Endothelial Growth Factor A Gene in Colorectal Cancer
31. The importance of −460 C/T and +405 G/C single nucleotide polymorphisms to the function of vascular endothelial growth factor A in colorectal cancer
32. Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature.
33. Non-CpG island promoter hypomethylation and miR-149 regulate the expression of SRPX2 in colorectal cancer.
34. Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature
35. Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature
36. Robust optimization of the Gross Tumor Volume compared to conventional Planning Target Volume-based planning in photon Stereotactic Body Radiation Therapy of lung tumors.
37. Quantitative analysis of vascular endothelial growth factor receptors 1 and 2 in colorectal cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.